首页> 外文OA文献 >Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results

【2h】

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results

机译：年龄，性别，肥胖和糖尿病对心肌灌注成像ADVANCE-MPI综合试验结果中选择性A2A激动剂Regadenoson与腺苷的疗效和安全性的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cerqueira Manuel D.; Nguyen Patricia; Staehr Peter; Underwood S. Richard; Iskandrian Ami E.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. [J] . Leaker BR, OConnor B, Hansel TT, Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology . 2008,第3期

机译：在轻度哮喘和中度哮喘患者中，regadenoson（一种用于心肌灌注显像的腺苷A2A受体激动剂）的安全性：一项随机，双盲，安慰剂对照试验。
2. The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. [J] . Thomas GS, Thompson RC, Miyamoto MI, Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology . 2009,第1期

机译：RegEx试验：在接受心肌灌注显像的患者中，一项将选择性A（2A）腺苷激动剂regadenoson与低水平运动相结合的随机，双盲，安慰剂和主动控制的试验研究。
3. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). [J] . Thomas GS, Tammelin BR, Schiffman GL, Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology . 2008,第3期

机译：regadenoson（一种选择性腺苷A2A激动剂）在慢性阻塞性肺疾病患者中的安全性：一项随机，双盲，安慰剂对照试验（RegCOPD试验）。
4. Safety and efficacy of Regadenoson in myocardial perfusion imaging (MPI) stress tests: A review [C] . Ambereen Ahmed Conference on quantitative phase imaging . 2018

机译：Regadenoson在心肌灌注成像（MPI）压力测试中的安全性和有效性：综述
5. Editorial: Regadenoson: An adenosine A2A receptor agonist for pharmacological myocardial perfusion imaging [O] . Shinro Matsuo 2014

机译：社论：Regadenoson：用于药理性心肌灌注成像的腺苷A2A受体激动剂
6. Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A(2A) Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results [O] . Cerqueira MD, Nguyen P, Staehr P, 2008

机译：年龄，性别，肥胖和糖尿病对选择性a（2a）激动剂Regadenoson与腺苷在心肌灌注成像中的有效性和安全性的影响综合aDVaNCE-mpI试验结果

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results

著录项

引文网络

相似文献

相关主题

期刊订阅